Clinical Trial Update: Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial in pediatric relapsed/refractory sarcomas evaluating hypofractionated radiation in combination with B7-H3-CAR T cells; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Osteosarcoma
• Rhabdomyosarcoma
• Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• B7-H3-CAR T cells (B7-H3-targeted CAR T cells)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Sarcoma, Childhood Osteosarcoma | Phase 1 | Status: RECRUITING